News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,821 Results
Type
Article (15679)
Company Profile (282)
Press Release (271860)
Multimedia
Podcasts (56)
Webinars (7)
Section
Business (84742)
Career Advice (321)
Deals (14626)
Drug Delivery (43)
Drug Development (53791)
Employer Resources (35)
FDA (6457)
Job Trends (5851)
News (155212)
Policy (11043)
Tag
Academia (981)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (22917)
ALS (64)
Alzheimer's disease (868)
Antibody-drug conjugate (ADC) (113)
Approvals (6494)
Artificial intelligence (128)
Autoimmune disease (19)
Automation (5)
Bankruptcy (115)
Best Places to Work (5229)
BIOSECURE Act (7)
Biosimilars (47)
Biotechnology (233)
Bladder cancer (64)
Brain cancer (23)
Breast cancer (184)
Cancer (1666)
Cardiovascular disease (122)
Career advice (271)
Career pathing (5)
CAR-T (124)
Cell therapy (342)
Cervical cancer (14)
Clinical research (44091)
Collaboration (566)
Compensation (265)
Complete response letters (13)
COVID-19 (1124)
CRISPR (44)
C-suite (167)
Cystic fibrosis (78)
Data (1623)
Denatured (11)
Depression (32)
Diabetes (153)
Diagnostics (1529)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (91)
Drug pricing (33)
Drug shortages (5)
Duchenne muscular dystrophy (90)
Earnings (32748)
Editorial (18)
Employer branding (5)
Employer resources (32)
Events (50506)
Executive appointments (468)
FDA (7210)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (511)
Gene editing (100)
Generative AI (10)
Gene therapy (258)
GLP-1 (394)
Government (1228)
Grass and pollen (2)
Guidances (31)
Healthcare (7253)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (96)
Indications (23)
Infectious disease (1193)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (47)
IPO (7883)
IRA (13)
Job creations (945)
Job search strategy (240)
Kidney cancer (8)
Labor market (8)
Layoffs (220)
Leadership (5)
Legal (1601)
Liver cancer (41)
Lung cancer (233)
Lymphoma (120)
Machine learning (3)
Management (7)
Manufacturing (154)
MASH (54)
Medical device (3293)
Medtech (3294)
Mergers & acquisitions (7088)
Metabolic disorders (422)
Multiple sclerosis (55)
NASH (14)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1287)
NextGen: Class of 2025 (2289)
Non-profit (973)
Now hiring (21)
Obesity (207)
Opinion (123)
Ovarian cancer (65)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (10)
Patents (137)
Patient recruitment (81)
Peanut (35)
People (26415)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14919)
Phase II (20158)
Phase III (13738)
Pipeline (867)
Policy (52)
Postmarket research (1046)
Preclinical (6232)
Press Release (31)
Prostate cancer (75)
Psychedelics (35)
Radiopharmaceuticals (221)
Rare diseases (298)
Real estate (1565)
Recruiting (14)
Regulatory (9382)
Reports (16)
Research institute (998)
Resumes & cover letters (45)
Rett syndrome (4)
RNA editing (5)
RSV (13)
Schizophrenia (61)
Series A (100)
Series B (64)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (119)
Sponsored (14)
Startups (2014)
State (1)
Stomach cancer (9)
Supply chain (25)
Tariffs (14)
The Weekly (44)
Vaccines (249)
Venture capitalists (32)
Weight loss (124)
Women's health (16)
Worklife (5)
Date
Today (119)
Last 7 days (569)
Last 30 days (1589)
Last 365 days (20498)
2025 (6645)
2024 (21570)
2023 (23476)
2022 (28099)
2021 (29198)
2020 (24929)
2019 (17943)
2018 (13126)
2017 (14699)
2016 (12812)
2015 (15462)
2014 (11224)
2013 (8132)
2012 (8288)
2011 (8442)
2010 (8112)
Location
Africa (173)
Alabama (42)
Alaska (2)
Arizona (56)
Arkansas (6)
Asia (18148)
Australia (3226)
California (3992)
Canada (1199)
China (386)
Colorado (156)
Connecticut (158)
Delaware (111)
Europe (40014)
Florida (480)
Georgia (121)
Idaho (17)
Illinois (249)
India (11)
Indiana (104)
Iowa (2)
Japan (85)
Kansas (66)
Kentucky (8)
Louisiana (3)
Maine (13)
Maryland (502)
Massachusetts (3151)
Michigan (72)
Minnesota (154)
Mississippi (1)
Missouri (25)
Montana (19)
Nebraska (5)
Nevada (20)
New Hampshire (17)
New Jersey (1079)
New Mexico (12)
New York (1092)
North Carolina (583)
North Dakota (5)
Northern California (1762)
Ohio (117)
Oklahoma (9)
Oregon (21)
Pennsylvania (765)
Puerto Rico (6)
Rhode Island (19)
South America (247)
South Carolina (4)
Southern California (1527)
Tennessee (31)
Texas (476)
United States (13883)
Utah (59)
Virginia (83)
Washington D.C. (32)
Washington State (363)
West Virginia (1)
Wisconsin (25)
287,821 Results for "plus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors
April 23, 2025
·
5 min read
Press Releases
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy
November 6, 2024
·
3 min read
Press Releases
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
March 10, 2025
·
4 min read
Press Releases
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
March 20, 2025
·
2 min read
Press Releases
Plus Therapeutics Announces New Employment Inducement Grants - March 5, 2025
March 6, 2025
·
2 min read
Press Releases
Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary
February 24, 2025
·
8 min read
Press Releases
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
February 21, 2025
·
7 min read
Press Releases
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
March 5, 2025
·
8 min read
Press Releases
Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 28, 2025
·
14 min read
Press Releases
Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
April 16, 2025
·
7 min read
1 of 28,783
Next
